Physiological and Therapeutic Roles of Neuropeptide Y on Biological Functions.
Anxiety
Brain
Depression
Obesity
Stress
Journal
Advances in experimental medicine and biology
ISSN: 0065-2598
Titre abrégé: Adv Exp Med Biol
Pays: United States
ID NLM: 0121103
Informations de publication
Date de publication:
2020
2020
Historique:
pubmed:
31
8
2019
medline:
6
2
2020
entrez:
31
8
2019
Statut:
ppublish
Résumé
Neuropeptide Y (NPY), an amino acid, used for various physiological processes for management and treatment of various ailments related to central nervous system, cardiovascular system, respiratory system, gastro-intestinal system and endocrinal system. In nasal mucosa, high concentrations of NPY are stored with noradrenaline in sympathetic nerve fibers. NPY Y
Identifiants
pubmed: 31468359
doi: 10.1007/5584_2019_427
doi:
Substances chimiques
Neuropeptide Y
0
Receptors, Neuropeptide Y
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
37-47Références
Ahrens VM, Kostelnik KB, Rennert R et al (2015) A cleavable cytolysin-neuropeptide Y bioconjugate enables specific drug delivery and demonstrates intracellular mode of action. J Control Release 209:170–178
pubmed: 25935706
Balasubramaniam A (1997) Neuropeptide Y family of hormones: receptor subtypes and antagonists. Peptides 18(3):445–457
pubmed: 9145434
Balasubramaniam A (2002) Clinical potentials of neuropeptide Y family of hormones. Am J Surg 183:430–434
pubmed: 11975932
Baraban SC (2004) Neuropeptide Y and epilepsy: recent progress, prospect and controversies. Neuropeptides 38:261–265
pubmed: 15337378
Beck B (2006) Neuropeptide Y in normal eating and in genetic and dietary-induced obesity. Philos Trans R Soc Lond Ser B Biol Sci 361:1159–1185
Botelho M, Cavadas C (2015) Neuropeptide Y: an anti-aging player? Trends Neurosci 38(11):701–711
pubmed: 26549884
Colmers WF, El Bahh BE (2003) Neuropeptide Y and epilepsy. Epilepsy Curr 3(2):53–58
pubmed: 15309085
pmcid: 321170
Cox HM (2007) Neuropeptide Y receptors; antisecretory control of intestinal epithelial function. Auton Neurosci 133(1):76–85
pubmed: 17140858
Decressac M, Barker RA (2012) Neuropeptide Y and its role in CNS disease and repair. Exp Neurol 238(2):265–272
pubmed: 23022456
Duarte-Neves J, Almeida LP, Cavadas C (2016) Neuropeptide Y (NPY) as a therapeutic target for neurodegenerative diseases. Neurobiol Dis 95:210–224
pubmed: 27461050
Dumont Y, Martel JC, Fournier A, St-Pierre S, Quirion R (1992) Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Prog Neurobiol 38(2):125–167
pubmed: 1312243
El Bahh BE, Balosso S, Hamilton T et al (2005) The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y2 and not Y5 receptors. Eur J Neurosci 22:1417–1430
pubmed: 16190896
Farzi A, Reichmann F, Holzar P (2015) The homeostatic role of neuropeptide Y in immune function and its impact on mood and behaviour. Acta Physiol (Oxford) 213(3):603–627
Geloso MC et al (2015) Cellular targets for neuropeptide Y-mediated control adult neurogenesis. Front Cell Neurosci 9:85
pubmed: 25852477
pmcid: 4360818
Gotzsche CR, Woldbye DP (2016) The role of NPY in learning and memory. Neuropeptides 55:79–89
pubmed: 26454711
Groneberg DA, Folkerts G, Peiser C (2004) Neuropeptide Y (NPY). Pulm Pharmacol Ther 17(4):173–180
pubmed: 15219262
Gumbs MC, van den Heuvel JK, la Fleur SE (2016) The effect of obesogenic diets on brain neuropeptide Y. Physiol Behav 162:161–173
pubmed: 27132202
Horsnell H, Baldock PA (2016) Osteoblastic actions of the neuropeptide Y system to regulate bone and energy homeostasis. Curr Osteoporos Rep 14(1):26–31
pubmed: 26872458
Huang L, Tan HY, Fogarty MJ et al (2014) Actions of NPY, and its Y1 and Y2 receptors on pulsatile growth hormone secretion during the fed and fasted state. J Neurosci 34(49):16309–16319
pubmed: 25471570
pmcid: 6608488
Iughetti L, Lucaccioni L, Fugetto F et al (2018) Brain-derived neurotrophic factor and epilepsy: a systematic review. Neuropeptides 72:23–29
pubmed: 30262417
Kautz M, Charney DS, Murrough JW (2017) Neuropeptide Y, resilience, and PTSD therapeutics. Neurosci Lett 649:164–169
pubmed: 27913193
Li L (2003) Neuropeptide Y- induced acceleration of postangioplasty occlusion of rat carotid artery. Arterioscler Thromb Vasc Biol 23(7):1204–1210
pubmed: 12689918
Liu W, Chen Y, Bai XW et al (2016) Identification and characterization of a novel neuropeptide (neuropeptide Y-HS) from leech salivary gland of Haemadipsa sylvestris. Chin J Nat Med 14(9):677–682
pubmed: 27667513
Loh K, Herzog H, Shi YC (2015) Regulation of energy homeostasis by the NPY system. Trends Endocrinol Metab 26(3):125–135
pubmed: 25662369
Malva JO, Xapelli S, Baptista S et al (2012) Multifaces of neuropeptide Y in the brain- neuroprotection, neurogenesis and neuroinflammation. Neuropeptides 46(6):299–308
pubmed: 23116540
Marchese E, Corvino V, Di Maria V et al (2018) The neuroprotective effects of 17-β-Estradiol Pretreatment in a model of neonatal hippocampal injury induced by trimethyltin. Front Cell Neurosci 12(385):1–18
Martin J, Elvas F, Brudzewsky D et al (2015) Activation of neuropeptide Y receptors modulates Retinal Ganglion Cell physiology and exerts neuroprotective actions in vitro. ASN Neuro 7(4):1–21
Mittapalli GK, Roberts E (2014) Ligands of the neuropeotide Y Y2 receptor. Bioorg Med Chem Lett 24(2):430–441
pubmed: 24365162
Munglani R, Hudspith MJ, Hunt SP (1996) The therapeutic potential of neuropeptide Y. Analgesic, anxiolytic and antihypertensive. Drugs 52(3):371–389
pubmed: 8875128
Noe F, Pool AH, Nissinen J et al (2008) Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy. Brain 131(Pt6):1506–1515
pubmed: 18477594
Pandit R, La Fleur SE, Adan RA (2013) The role of melanocortins and neuropeptide Y in food reward. Eur J Pharmacol 719(1–3):208–214
pubmed: 23872406
Park MH et al (2015) Neuropeptide Y regulates the hematopoietic stem cell microenvironment and prevents nerve injury in the bone marrow. EMBO J 34(12):1648–1660
pubmed: 25916827
pmcid: 4475399
Parker EM, Babij CK, Balasubramaniam A et al (1998) GR231118 (1229U91) and other analogues of the C-terminus of neuropeptide Y are potent neuropeptide Y Y
pubmed: 9669502
Pedrazzini T, Pralong F, Grouzmann E (2003) Neuropeptide Y: the universal soldier. Cell Mol Life Sci 60(2):350–377
pubmed: 12678499
Peng S, Zhou Y et al (2017) Effects of neuropeptide Y on stem cells and their potential applications in disease therapy. Stem Cells Int 2017:6823917
pubmed: 29109742
pmcid: 5646323
Qiao Y, Wang Y, Zhou Y et al (2018) The role of nervous system in adaptive response of bone to mechanical loading. J Cell Physiol 234(6):7771–7780
pubmed: 30414185
Quirion R, Dumont Y, Carvajal C (2006) Neuropeptide Y: role in emotion and alcohol dependence. CNS Neurol Disord Drug Targets 5(2):181–195
pubmed: 16611091
Rasmusson AN (2017) The gut peptide neuropeptide Y and post-traumatic stress disorder. Curr Opin Endocrinol Diabetes Obes 24(1):3–8
pubmed: 27898588
Reibel S, Nadi S, Benmaamar R et al (2001) Neuropeptide Y and epilepsy: varying effects according to seizure type and receptor activation. Peptides 22(3):529–539
pubmed: 11287111
Reichmann F, Holzer P (2016) Neuropeptide Y: A stressful review. Neuropeptides 55:99–109
pubmed: 26441327
Robinson SL, Thiele TE (2017) The role of neuropeptide Y (NPY) in alcohol and drug abuse disorders. Int Rev Neurobiol 136:177–197
pubmed: 29056151
Sabban EL, Alaluf LG, Serova LI (2016) Potential of neuropeptide Y for preventing or treating post-traumatic stress disorder. Neuropeptides 56:19–24
pubmed: 26617395
Sah R, Geracioti TD (2013) Neuropeptide Y and posttraumatic stress disorder. Mol Psychiatry 18(6):646–655
pubmed: 22801411
Santos-Carvalho A, Ambrosio AF, Cavadas C (2015) Neuropeptide Y system in the retina: from localization to function. Prog Retin Eye Res 47:19–37
pubmed: 25797468
Saraf R, Mahmood F, Amir R et al (2016) Neuropeptide Y is an angiogenic factor in cardiovascular regeneration. Eur J Pharmacol 776:64–70
pubmed: 26875634
Shipp SL, Cline MA, Gilbert ER (2016) Promotion of adipogenesis by neuropeptide Y during the later stages of chicken preadipocyte differentiation. Phys Rep 4(21):1–12
Silva AP, Cavadas C, Grouzmann E (2002) Neuropeptide Y and its receptors as potential therapeutic drug targets. Clin Chim Acta 326:3–25
pubmed: 12417094
Sun WW, Zhu P, Shi YC et al (2017) Current views on neuropeptide Y and diabetes-related artherosclerosis. DiabVas Dis Res 14(4):277–284
Tan CMJ, Green P, Tapoulal N et al (2018) The role of neuropeptide Y in cardiovascular health and disease. Front Physiol 9(1281):1–13
Tasan RO, Verma D, Wood J et al (2016) The role of Neuropeptide Y in fear conditioning and extinction. Neuropeptides 55:111–126
pubmed: 26444585
Tilan J, Kitlinska J (2016) Neuropeptide Y (NPY) in tumor growth and progression: lessons learned from pediatric oncology. Neuropeptides 55:55–66
pubmed: 26549645
Van den Heuvel JK, Eggels L, van Rozen AJ et al (2014) Neuropeptide Y and leptin sensitivity is dependent on diet composition. J Neuroendocrinol 26(6):377–385
pubmed: 24698502
Vazquez-Leon P, Mendoza-Ruiz LG, Juan ER et al (2017) Analgesic and anxiolytic effects of [Leu
pubmed: 29042065
Woldbye DP, Kokaia M (2004) Neuropeptide Y and seizures: effects of exogenously applied ligands. Neuropeptides 38(4):253–360
pubmed: 15337377
Wu G, Feder A, Wegener G et al (2011) Central functions of neuropeptide Y in mood and anxiety disorders. Expert Opin Ther Targets 15(11):1317–1331
pubmed: 21995655
Zhang L, Bijker MS, Herzog H (2011) The neuropeptide Y system: pathophysiological and therapeutic implications in obesity and cancer. Pharmacol Ther 131(1):91–113
pubmed: 21439311